Buddha Basnyat
Buddha Basnyat
Director, Oxford University Clinical Research Unit\Nepal
Adresse e-mail validée de
Citée par
Citée par
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
CJL Murray, KS Ikuta, F Sharara, L Swetschinski, GR Aguilar, A Gray, ...
The Lancet 399 (10325), 629-655, 2022
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
O Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...
The Lancet 397 (10285), 1637-1645, 2021
High-altitude illness
B Basnyat, DR Murdoch
The Lancet 361 (9373), 1967-1974, 2003
Acute high-altitude illnesses
P Bärtsch, ER Swenson
New England Journal of Medicine 368 (24), 2294-2302, 2013
Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter-and intracontinental transmission events
VK Wong, S Baker, DJ Pickard, J Parkhill, AJ Page, NA Feasey, ...
Nature genetics 47 (6), 632-639, 2015
Antimicrobial Drug Resistance of Salmonella enterica Serovar Typhi in Asia and Molecular Mechanism of Reduced Susceptibility to the Fluoroquinolones
TT Chau, JI Campbell, CM Galindo, N Van Minh Hoang, TS Diep, ...
Antimicrobial agents and chemotherapy 51 (12), 4315-4323, 2007
The etiology of febrile illness in adults presenting to Patan hospital in Kathmandu, Nepal
DR Murdoch, CW Woods, MD Zimmerman, PM Dull, RH Belbase, ...
The American journal of tropical medicine and hygiene 70 (6), 670-675, 2004
Salmonella enterica Serovar Paratyphi A and S. enterica Serovar Typhi Cause Indistinguishable Clinical Syndromes in Kathmandu, Nepal
AP Maskey, JN Day, PQ Tuan, GE Thwaites, JI Campbell, M Zimmerman, ...
Clinical infectious diseases 42 (9), 1247-1253, 2006
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RC Group
The Lancet Respiratory Medicine 9 (12), 1419-1426, 2021
Admixture facilitates genetic adaptations to high altitude in Tibet
C Jeong, G Alkorta-Aranburu, B Basnyat, M Neupane, DB Witonsky, ...
Nature communications 5 (1), 1-7, 2014
Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of …
JH Gertsch, B Basnyat, EW Johnson, J Onopa, PS Holck
Bmj 328 (7443), 797, 2004
Efficacy of low-dose acetazolamide (125 mg BID) for the prophylaxis of acute mountain sickness: a prospective, double-blind, randomized, placebo-controlled trial
B Basnyat, JH Gertsch, EW Johnson, F Castro-Marin, Y Inoue, C Yeh
High altitude medicine & biology 4 (1), 45-52, 2003
Maximising access to achieve appropriate human antimicrobial use in low-income and middle-income countries
M Mendelson, JA Røttingen, U Gopinathan, DH Hamer, H Wertheim, ...
The Lancet 387 (10014), 188-198, 2016
A current perspective on antimicrobial resistance in Southeast Asia
RM Zellweger, J Carrique-Mas, D Limmathurotsakul, NPJ Day, ...
Journal of Antimicrobial Chemotherapy 72 (11), 2963-2972, 2017
Genome-wide association study identifies five new susceptibility loci for primary angle closure glaucoma
CC Khor, T Do, H Jia, M Nakano, R George, K Abu-Amero, R Duvesh, ...
Nature genetics 48 (5), 556-562, 2016
Disoriented and ataxic pilgrims: an epidemiological study of acute mountain sickness and high-altitude cerebral edema at a sacred lake at 4300 m in the Nepal Himalayas
B Basnyat, D Subedi, J Sleggs, J Lemaster, G Bhasyal, B Aryal, N Subedi
Wilderness & environmental medicine 11 (2), 89-93, 2000
Emerging trends in enteric fever in Nepal: 9124 cases confirmed by blood culture 1993–2003
AP Maskey, B Basnyat, GE Thwaites, JI Campbell, JJ Farrar, ...
Transactions of the Royal Society of Tropical Medicine and Hygiene 102 (1 …, 2008
Everest or bust: a cross sectional, epidemiological study of acute mountain sickness at 4243 meters in the Himalayas.
B Basnyat, J Lemaster, JA Litch
Aviation, space, and environmental medicine 70 (9), 867-873, 1999
Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness: the prophylactic acetazolamide dosage comparison for …
B Basnyat, JH Gertsch, PS Holck, EW Johnson, AM Luks, BP Donham, ...
High Altitude Medicine & Biology 7 (1), 17-27, 2006
Clinical recommendations for high altitude exposure of individuals with pre-existing cardiovascular conditions: A joint statement by the European Society of Cardiology, the …
G Parati, P Agostoni, B Basnyat, G Bilo, H Brugger, A Coca, L Festi, ...
European heart journal 39 (17), 1546-1554, 2018
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20